Trial | NCT01347814  Report issue

Title

Effect of 10mg Domperidone on Gastric Emptying of a High-fat Meal and Appetite Sensations in Healthy Adults
Does Domperidone, a D2-antagonist Alter Gastric Emptying Rates and Appetite Sensations in Healthy Adults?

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    domperidone ...

  • Study Participants

    13
The purpose of this study is to determine whether domperidone was sufficient to accelerate gastric emptying of a high-fat solid meal and reduce satiety responses in a healthy adult population.
This study aims to investigate the effect of domperidone on gastric emptying and appetite sensations in healthy subjects. Domperidone is a dopamine 2 (D2) receptor antagonist with claims of gastrointestinal tract pro-kinetic activity. Accelerated gastric emptying (GE) may lead to reduced satiation, increased food intake and is associated with obesity and diabetes mellitus. It is hypothesized that domperidone will increase gastric emptying rate and reduce satiety responses to a high-fat meal.

The effect of acute oral administration of 10 mg domperidone on gastric emptying of a high-fat pancake test meal, and subjective appetite sensations by visual analogue scale will be measured for six hours postprandially in a randomized, placebo-controlled, single-blinded manner in 13 healthy subjects.
Study Started
Feb 29
2008
Primary Completion
Apr 30
2010
Study Completion
Apr 30
2010
Last Update
May 04
2011
Estimate

Drug Domperidone 10mg

10mg domperidone tablet 30 minutes before a test-meal.

  • Other names: Motilium

Drug Placebo

Homeopathic (Sugar) pill-Placebo

  • Other names: Homeopathic medicine; Silicea, 6c, Weleda, Derbyshire, UK

Criteria 

Inclusion Criteria:

Healthy adults aged 18-40 years

Exclusion Criteria:

History of gastrointestinal-related conditions, diabetes mellitus or cardiovascular disease
No Results Posted